EMILY CAMPBELL: Open Payments
NPI 1306578315 · GRETNA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,243 in 67 payments from 14 companies in 2025. Trend: 2023 $1,322 · 2024 $1,135 · 2025 $1,243
Food & beverage: $1,157Education: $86
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $378 |
| GENZYME CORPORATION | 11 | $288 |
| Janssen Biotech, Inc. | 6 | $184 |
| E.R. Squibb & Sons, L.L.C. | 10 | $137 |
| Amgen Inc. | 3 | $43 |
| Lilly USA, LLC | 1 | $34 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $31 |
| SpringWorks Therapeutics, Inc. | 1 | $28 |
| LNHC, Inc | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, Sotyktu, RINVOQ, OTEZLA, EBGLYSS, Neo-Synalar.
Industry payments across LA — which companies pay providers there.
